Very excited to be presenting my research on the microbial landscape of NSCLC in collaboration with TRACERx at the #UCLCancerDomain

We won the first ever Crick Innovation Challenge last week with our idea to build an AI-driven app for multi-morbidity that could be integrated into primary care - grateful for the experience and congrats team! Crick Science Entrepreneur Network (CSEN)

We are very happy to announce the launch of our new initiative The Excellerator, a Leadership Programme! It aims to accelerate the development of leadership skills in young scientific talent. #biotech #team #leadership #lifesciences #future #development

⁦Science Museum⁩ with the lung cancer team ⁦UCL Cancer Institute⁩ ⁦CRUK Lung Centre⁩ ⁦Roger Highfield⁩ for the lung cancer centre conference ⁦Science and Innovation at Cancer Research UK⁩ what a fabulous conference

What makes a good leader? As we gear up for GBR’s first Excellerator program, it is an opportune time to ponder over that question. Head over to our blog to find out more from Madhuri Manohar. The link to the article: globalbiotechrevolution.com/a-good-leader-…

Today our important study on air pollutants in the promotion of lung cancer has been published in nature led by Will Hill Emilia Lim Clare Weeden Swanton Lab ...Thread below🧵nature.com/articles/s4158…

Over the last month, we have been working on building ML models to explore the role of the microbiome on soil health in the AI4LifeSciences hackathon and I am proud to announce that we won 2nd place from 53 teams! You can check out our solution here (merrymicrobes.wordpress.com)

What is the role of the TME in lung cancer evolution? We are excited to share our new TRACERx paper “Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer” at #AACR24, out in Cancer Discovery today rb.gy/q484j9 Tweetorial👇

My 2nd AACR annual conference and I had the opportunity to present our recent work on the CPI3000+ as a poster - great discussion and feedback! #AACR24

Poster 3/6 from the Kevin Litchfield lab at AACR! In this session we have Marcellus Augustine presenting his exciting work on the MIDAS project to identify novel immunotherapy targets (section 25, board 1)

Poster 4/6 from the AACR conference from the Litchfield lab! Shanila presented her work on nonsense-mediated decay for the first time and it generated a lot of interest!

On the final day of AACR, we have poster 6/6 from our senior post-doc Roberto Vendramin from the UCL Cancer Institute institute presenting the work on the NMD pathway! The paper is now a preprint at dx.doi.org/10.2139/ssrn.4… #AACR24

Did not get the chance to post this on the very packed first day of AACR but the first poster from our lab was @robinson_welles presenting his work on the TIL-ACT project - it generated alot of exciting discussions and was a great start to showcasing the labs research! #AACR24

Had a blast at my first #AACR. Ton of great science and great feedback on our work on inducing anti tumour immunogenicity by inhibiting the NMD pathway. Thanks to Kevin Litchfield and Charles Swanton for the great supervision and to our sponsors Cancer Research Horizons CRUKCOLcentre Cancer Research UK

Poster 5/6 from our lab at AACR was Evie Fitzsimons - she presented her work on the NIMBLE clinical study on lung cancer early detection. If you want to know more here is an article from Science and Innovation at Cancer Research UK news.cancerresearchuk.org/2024/03/15/unl… #AACR24